X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4580) 4580
science & technology (4049) 4049
life sciences & biomedicine (3990) 3990
male (3676) 3676
female (3383) 3383
hepatectomy - adverse effects (3112) 3112
surgery (3101) 3101
middle aged (3027) 3027
aged (2462) 2462
liver neoplasms - surgery (2288) 2288
adult (2230) 2230
hepatectomy (2002) 2002
treatment outcome (1957) 1957
hepatectomy - methods (1737) 1737
gastroenterology & hepatology (1515) 1515
retrospective studies (1501) 1501
liver (1218) 1218
risk factors (1185) 1185
time factors (1061) 1061
carcinoma, hepatocellular - surgery (1021) 1021
liver neoplasms - mortality (960) 960
liver neoplasms - secondary (959) 959
aged, 80 and over (865) 865
liver neoplasms - pathology (859) 859
hepatectomy - mortality (827) 827
medicine & public health (813) 813
abridged index medicus (771) 771
animals (690) 690
prognosis (679) 679
oncology (669) 669
colorectal neoplasms - pathology (644) 644
liver cancer (630) 630
hepatocellular carcinoma (617) 617
survival rate (604) 604
analysis (603) 603
gastroenterology (572) 572
carcinoma, hepatocellular - pathology (523) 523
liver - surgery (522) 522
follow-up studies (516) 516
carcinoma, hepatocellular - mortality (514) 514
metastasis (509) 509
disease-free survival (492) 492
risk assessment (480) 480
young adult (468) 468
postoperative complications - etiology (447) 447
liver - pathology (443) 443
transplantation (441) 441
cancer (440) 440
adolescent (427) 427
prospective studies (420) 420
survival analysis (402) 402
multivariate analysis (399) 399
mortality (394) 394
neoplasm staging (394) 394
liver neoplasms - therapy (393) 393
health aspects (385) 385
gastroenterology and hepatology (382) 382
liver transplantation (380) 380
liver transplantation - adverse effects (376) 376
hepatology (373) 373
kaplan-meier estimate (371) 371
living donors (371) 371
hepatoma (369) 369
liver resection (369) 369
care and treatment (365) 365
length of stay (353) 353
abdominal surgery (345) 345
rats (328) 328
liver regeneration (313) 313
postoperative complications (308) 308
chemotherapy (305) 305
colorectal cancer (302) 302
liver diseases (294) 294
liver neoplasms - drug therapy (293) 293
postoperative complications - epidemiology (288) 288
tomography, x-ray computed (286) 286
liver diseases - surgery (285) 285
original (285) 285
liver transplantation - methods (273) 273
chi-square distribution (265) 265
proportional hazards models (261) 261
surgical oncology (253) 253
laparoscopy (252) 252
predictive value of tests (251) 251
chemotherapy, adjuvant (243) 243
laparoscopy - adverse effects (242) 242
patient selection (241) 241
blood loss, surgical - prevention & control (236) 236
liver function tests (236) 236
patients (235) 235
combined modality therapy (231) 231
neoplasm recurrence, local (227) 227
liver - blood supply (225) 225
bile duct neoplasms - surgery (224) 224
thoracic surgery (218) 218
cardiac surgery (215) 215
liver failure - etiology (214) 214
vascular surgery (213) 213
carcinoma, hepatocellular - therapy (212) 212
liver cirrhosis (209) 209
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5049) 5049
Japanese (91) 91
Russian (79) 79
French (77) 77
German (45) 45
Chinese (44) 44
Spanish (26) 26
Portuguese (17) 17
Hungarian (13) 13
Italian (12) 12
Polish (8) 8
Romanian (8) 8
Danish (7) 7
Czech (5) 5
Ukrainian (4) 4
Bulgarian (3) 3
Norwegian (2) 2
Croatian (1) 1
Dutch (1) 1
Hebrew (1) 1
Icelandic (1) 1
Korean (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The lancet oncology, ISSN 1470-2045, 10/2015, Volume 16, Issue 13, pp. 1344 - 1354
Summary Background There is no standard of care for adjuvant therapy for patients with hepatocellular carcinoma. This trial was designed to assess the efficacy... 
Hematology, Oncology and Palliative Medicine | Catheter Ablation - mortality | South America | Carcinoma, Hepatocellular - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Hepatectomy - mortality | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | North America | Young Adult | Carcinoma, Hepatocellular - drug therapy | Time Factors | Aged, 80 and over | Liver Neoplasms - pathology | Catheter Ablation - adverse effects | Chemotherapy, Adjuvant | Europe | Risk Factors | Niacinamide - adverse effects | Niacinamide - therapeutic use | Disease Progression | New Zealand | Protein Kinase Inhibitors - administration & dosage | Intention to Treat Analysis | Niacinamide - analogs & derivatives | Liver Neoplasms - mortality | Antineoplastic Agents - adverse effects | Phenylurea Compounds - adverse effects | Adult | Female | Double-Blind Method | Hepatectomy - adverse effects | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Neoplasm Recurrence, Local | Phenylurea Compounds - therapeutic use | Carcinoma, Hepatocellular - surgery | Liver Neoplasms - surgery | Treatment Outcome | Niacinamide - administration & dosage | Disease-Free Survival | Phenylurea Compounds - administration & dosage | Asia | Protein Kinase Inhibitors - therapeutic use | Carcinoma, Hepatocellular - pathology | Aged | Australia | Antimitotic agents | Liver cancer | Medical colleges | Surgery | Liver | Clinical trials | Hepatoma | Antineoplastic agents | Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 2010, Volume 11, Issue 1, pp. 38 - 47
Summary Background Neoadjuvant chemotherapy for unresectable colorectal liver metastases can downsize tumours for curative resection. We assessed the... 
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Antineoplastic Agents - therapeutic use | Tomography, Spiral Computed | Liver Neoplasms - chemistry | Hepatectomy | Antibodies, Monoclonal, Humanized | Fluorouracil - therapeutic use | Austria | Leucovorin - adverse effects | Fluorouracil - adverse effects | Time Factors | Antineoplastic Agents - adverse effects | Female | Leucovorin - therapeutic use | Neoadjuvant Therapy | Retrospective Studies | Chemotherapy, Adjuvant | Cetuximab | Liver Neoplasms - secondary | Odds Ratio | Camptothecin - analogs & derivatives | Camptothecin - adverse effects | Camptothecin - therapeutic use | Liver Neoplasms - genetics | Risk Assessment | Liver Neoplasms - drug therapy | Linear Models | Liver Neoplasms - surgery | Proto-Oncogene Proteins - genetics | Treatment Outcome | Receptor, Epidermal Growth Factor - analysis | Magnetic Resonance Imaging | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Aged | Mutation | Colorectal Neoplasms - pathology | Organoplatinum Compounds - therapeutic use | Germany | Organoplatinum Compounds - adverse effects | Index Medicus
Journal Article
British journal of cancer, ISSN 1532-1827, 11/2012, Volume 107, Issue 12, pp. 1932 - 1937
Journal Article
Journal of gastrointestinal surgery, ISSN 1091-255X, 1/2013, Volume 17, Issue 1, pp. 195 - 202
Journal Article